Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial

Clinical trial NCT06974968 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06974968
Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injury Safety Efficacy Clinical Trial Induced Pluripotent Stem Cells Human Motor Neuron Progenitor Transplantation RCT

Start date: 2028-05-25
Primary completion: 2031-05-25
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.